Join the Oncology Voice Network. Join for Free
MSL Onboarding, Training and the first 60 days with Maria Urso
MSL onboarding MSL training pharma career MSL exam preparation qualities of MSLs

MSL Onboarding, Training and the first 60 days with Maria Urso


Share This Article


Summary

In this episode, my guest is Maria Urso. Maria is the Associate Director of MSLs for Exact Sciences. We talk about MSL onboarding, training, and the first 60 days as an MSL in addition to some other things.

In this episode:

  • How Maria ended up in pharma
  • Maria’s view on the onboarding, training, and the exam
  • Advice for MSLs to help them get prepared for onboarding
  • What can someone expect from a day-to-day perspective
  • How important is it to follow the syllabus
  • What materials to expect
  •  How to stay focused while having the syllabus
  • How to prepare for the exam
  • The presentation on the exam and the interview
  • What qualities Maria look for in MSLs
  •  Crazy interview stories 
  • Advice for someone who's trying to break into the industry
  • Final advice for someone who is about to start their onboarding or about finish or going out into the field

Click for Source
MSL onboarding, MSL training, pharma career, MSL exam preparation, qualities of MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Podcast
Prepare to LAUNCH: How to Build an MSL Team From Scratch
Partner Avatar MSL Talk: Tom Caravela, John Caskey

Prepare to LAUNCH: How to Build an MSL Team From Scratch

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Outcome measures for oncology alternative payment models: practical considerations and recommendations
OVN Avatar Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD

Outcome measures for oncology alternative payment models: practical considerations and recommendations

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Explore OVN